Verheggen P W, de Maat M P, Cats V M, Haverkate F, Zwinderman A H, Kluft C, Bruschke A V
Department of Cardiology, Leiden University Medical Centre, The Netherlands.
Eur Heart J. 1999 Apr;20(8):567-74. doi: 10.1053/euhj.1998.1312.
Inflammation, endothelial cell function and the coagulation system have been demonstrated to be involved in the onset and course of unstable angina. Whether a proinflammatory state independently determines outcome is unknown and has not been determined yet in a clinically well defined study population of consecutive patients admitted with unstable angina.
Markers of inflammation, coagulation activation and endothelial cell function were determined on admission in blood of 211 consecutive patients with severe unstable angina and were related to the in-hospital course. Refractory unstable angina occurred in 76 patients (36%) during their hospital stay. In a univariate analysis, C-reactive protein (P = 0.03), fibrinogen (P < 0.001) and erythrocyte sedimentation rate (P = 0.001) levels were significantly higher in patients with refractory unstable angina, when compared with patients who had an uneventful clinical course. The odds ratios (95% CI) adjusted for age, sex, body mass index, smoking behaviour and cholesterol levels of the occurrence of refractory unstable angina for patients in the highest quartile compared with patients in the lowest quartile of inflammatory markers were 2.19 (0.94-5.11) for C-reactive protein, 2.83 (1.13-7.10) for fibrinogen and 4.72 (1.70-13.09) for the erythrocyte sedimentation rate. The findings were not affected by the presence or absence of myocardial necrosis or the interval between onset of angina and blood collection. No association was found between markers of coagulation activation or markers of endothelial cell function, and in-hospital outcome.
We found that in a clinically well-defined study population of patients with severe unstable angina, a proinflammatory state is an important and independent determinant of short-term outcome. The data strengthen the importance of inflammation in this syndrome.
炎症、内皮细胞功能和凝血系统已被证明与不稳定型心绞痛的发病和病程有关。促炎状态是否独立决定预后尚不清楚,且在连续收治的不稳定型心绞痛临床明确的研究人群中尚未得到确定。
对211例严重不稳定型心绞痛连续患者入院时血液中的炎症、凝血激活和内皮细胞功能标志物进行测定,并与住院病程相关联。76例患者(36%)在住院期间发生难治性不稳定型心绞痛。单因素分析显示,与临床病程平稳的患者相比,难治性不稳定型心绞痛患者的C反应蛋白(P = 0.03)、纤维蛋白原(P < 0.001)和红细胞沉降率(P = 0.001)水平显著更高。与炎症标志物最低四分位数的患者相比,最高四分位数的患者发生难治性不稳定型心绞痛的比值比(及95%置信区间)经年龄、性别、体重指数、吸烟行为和胆固醇水平校正后,C反应蛋白为2.19(0. 94 - 5.11),纤维蛋白原为2.83(1.13 - 7.10),红细胞沉降率为4.72(1.70 - 13.09)。这些发现不受心肌坏死的有无或心绞痛发作与采血之间间隔时间的影响。未发现凝血激活标志物或内皮细胞功能标志物与住院结局之间存在关联。
我们发现在临床明确的严重不稳定型心绞痛患者研究人群中,促炎状态是短期预后的重要且独立的决定因素。这些数据强化了炎症在该综合征中的重要性。